Log in or Sign up for Free to view tailored content for your specialty!
Motility News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS.
Prucalopride still effective in CIC despite older age, unhealthy BMI or renal impairment
Prucalopride was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with chronic idiopathic constipation, regardless of age, BMI or renal function, according to data.
Constipation Awareness Month seeks to ‘normalize conversations about digestive health’
Although constipation affects millions of people worldwide, it remains one of the least discussed health concerns due to social stigma, according to a press release from the International Foundation for Gastrointestinal Disorders.
Log in or Sign up for Free to view tailored content for your specialty!
Angiotensin receptor blockers ‘may not be safe,’ worsen outcomes for celiac disease
PHILADELPHIA — Angiotensin receptor blockers were associated with worse outcomes in patients with celiac disease, including anemia, iron deficiency and “continued mucosal damage in the small intestine,” according to a presenter.
Atmo capsule may offer ‘potential replacement’ for nixed SmartPill in motility disorders
PHILADELPHIA — An ingestible gas-sensing capsule from Atmo Biosciences showed “substantial agreement” with the discontinued Medtronic wireless motility device for measuring regional transit times in gastrointestinal motility disorders.
No difference in stool frequency with B. lactis HN019 vs. placebo in constipation
Daily consumption of Bifidobacterium animalis subsp lactis HN019 did not increase complete spontaneous bowel movements per week vs. placebo in healthy individuals with functional constipation, according to a study in JAMA Network Open.
New guideline highlights ‘individualized approach’ in management of chronic constipation
An updated clinical practice guideline from The American Society of Colon and Rectal Surgeons underscored the need for collaborative, cross-specialty care to achieve “optimal patient outcomes” in chronic constipation.
‘Bad guys’ in the gut: Archaea overgrowth linked to severe constipation
The prevalence and severity of constipation was significantly higher in patients with intestinal methanogen overgrowth, underscoring the importance of diagnostic and treatment strategies specific to archaea overgrowth, researchers wrote.
Vanda’s tradipitant falls short for gastroparesis as FDA requests ‘additional studies’
The FDA has issued a complete response letter to Vanda Pharmaceuticals indicating it cannot approve the company’s new drug application seeking approval for tradipitant as a treatment for gastroparesis.
Q&A: Advise patients of ‘healthy diet, lifestyle choices at any age’ to avoid bloating
Occasional bloating is common in most individuals, but for some, aging can contribute to an increase in gas as gastrointestinal motility slows, leading to an uptick in bloating and other GI symptoms.
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read